You are viewing all posts tagged with "Basel III"

vice president, SunGard’s capital markets business

5
Dec
2012

U.S. Banks: Hello to 2013, Goodbye to Basel III?

Contributor:

This blog post was originally published in Wall Street Letter. Industry participants that oppose the onerous and complicated requirements of Basel III may succeed in permanently eliminating a U.S. implementation. Although it is likely that enhanced capital and risk standards, as mandated by the Dodd-Frank Act (“DFA”) will be implemented, they may however, depending on certain pending initiatives, be prescribed through government and industry collaboration. In response to a request by industry participants, the U.S. federal banking agencies, on November 9, 2012, released a joint release indefinitely delaying the January 1, 2013 U.S. implementation of Basel III.... read more

Commentary from SunGard experts on news and events affecting the financial services industry.

17
Aug
2012

SUNGARD VIEWPOINT: Basel III

Contributor:

Q&A with Mat Newman, vice president, product management, SunGard's capital markets business Q: In June the Federal Reserve announced what was called by some a rigorous interpretation of Basel III, the international agreement on higher capital standards for banks. What are three key points that people need to understand about this development? A:...... read more

Gavin Lee, chief operating officer, FastVal, SunGard’s asset management business

18
May
2012

Central clearing of complex OTC derivatives: Trying to put a square peg in a round hole

Contributor:

The concept of centrally clearing all OTC derivatives - both standardized and complex derivatives - is flawed. The current regulatory expectation for institutional investors is to go through a central clearing party for an expanded range of products. Compounding this requirement is that derivatives will need to be reported through trade repositories. This means that derivative products have to be cleared through a central counterparty, but not every derivative instrument fits this model.... read more

vice president, collateral management, SunGard's capital markets business

26
Mar
2012

2012: The tipping point for enterprise collateral management and optimization

Contributor:

This blog post originally appeared on TabbFORUM. This is the year that regulatory changes are starting to bite. Dodd-Frank, EMIR and Basel III are all combining to fuel huge growth in the demand for high-quality assets for use as collateral and to maintain liquidity levels. To add to the complexity, we are experiencing a simultaneous drop in the availability of these in-demand assets. These things together have created the infamous collateral squeeze.... read more

global head of strategy, SunGard's capital markets business

16
Dec
2011

10 trends in OTC derivatives

Contributor:

It is clear that regulatory changes are transforming the OTC derivatives space, from execution to settlement. There are many challenges at play here. As we head into 2012, market participants will need to manage large volumes of data in order to clear and process trades, and we will see new pressures on the cost and the more effective use of capital. In response to this industry transformation, my team and I have identified 10 key trends shaping OTC derivatives today.... read more